Free tool
Stocks above their 200-day average
We cover 235 companies trading above their own 200-day average. The median market value in the group is $2.26B. Across the group, the median move over the past trading day is −0.05%. 100% of the 235 with a 200-day average trade above it. Price change over the past year runs from −32.2% to +311.4% across the middle 80 percent of the group, with a median of +54.3%. Across the group, 2 companies currently carry a tier A volume signal.
Other lists in this group
Table
235 of 10,735 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| AVTR | Avantor, Inc. | $9.81B | Mid cap | +9.93% |
| PTGX | Protagonist Therapeutics, Inc. | $9.80B | Mid cap | +146.62% |
| NUVL | Nuvalent Inc | $9.79B | Mid cap | +62.83% |
| BIO-B | Bio-Rad Laboratories, Inc. | $9.77B | Mid cap | +47.78% |
| OSCR | Oscar Health, Inc. | $9.55B | Mid cap | +83.55% |
| TWST | Twist Bioscience Corporation | $9.41B | Mid cap | +451.89% |
| PCVX | Vaxcyte, Inc. | $9.09B | Mid cap | +99.97% |
| IMVT | Immunovant, Inc. | $9.07B | Mid cap | +189.13% |
| QGEN | Qiagen N.V. | $9.01B | Mid cap | −9.65% |
| CRNX | Crinetics Pharmaceuticals, Inc. | $9.00B | Mid cap | +179.08% |
| HQY | HealthEquity, Inc. | $8.75B | Mid cap | +18.69% |
| BRKR | Bruker Corporation | $8.69B | Mid cap | +70.56% |
| ATR | AptarGroup, Inc. | $8.60B | Mid cap | −1.89% |
| TGTX | TG Therapeutics, Inc. Common Stock | $8.42B | Mid cap | +92.61% |
| TXG | 10x Genomics, Inc. | $8.37B | Mid cap | +358.35% |
| ALKS | Alkermes plc | $8.25B | Mid cap | +68.07% |
| SYRE | Spyre Therapeutics, Inc. | $8.13B | Mid cap | +446.12% |
| RYTM | Rhythm Pharmaceuticals, Inc. | $7.78B | Mid cap | +9.35% |
| CAI | Caris Life Sciences, Inc. | $7.58B | Mid cap | −29.83% |
| SRRK | Scholar Rock Holding Corporation | $7.31B | Mid cap | +74.18% |
| HNGE | Hinge Health, Inc. | $7.25B | Mid cap | +56.66% |
| CHE | Chemed Corporation | $7.11B | Mid cap | +20.79% |
| PACS | PACS Group, Inc. | $7.03B | Mid cap | +274.28% |
| HIMS | Hims & Hers Health, Inc. | $6.96B | Mid cap | −32.22% |
| CGON | CG Oncology, Inc. | $6.95B | Mid cap | +196.15% |
| ERAS | Erasca, Inc. | $6.70B | Mid cap | +1112.03% |
| LNTH | Lantheus Holdings, Inc. | $6.58B | Mid cap | +77.38% |
| ORKA | Oruka Therapeutics, Inc. | $6.58B | Mid cap | +555.07% |
| BLTE | Belite Bio, Inc | $6.31B | Mid cap | +144.07% |
| LQDA | Liquidia Corporation | $6.31B | Mid cap | +154.86% |
| CNTA | Centessa Pharmaceuticals plc | $6.27B | Mid cap | +143.24% |
| AMRX | Amneal Pharmaceuticals, Inc. | $6.27B | Mid cap | +92.20% |
| TVTX | Travere Therapeutics, Inc. | $6.24B | Mid cap | +284.86% |
| XENE | Xenon Pharmaceuticals Inc. | $6.18B | Mid cap | +64.11% |
| BLCO | Bausch + Lomb Corporation | $6.16B | Mid cap | +18.56% |
| DNTH | Dianthus Therapeutics, Inc. | $6.13B | Mid cap | +356.93% |
| STVN | Stevanato Group S.p.A. | $6.11B | Mid cap | −0.09% |
| KNSA | Kiniksa Pharmaceuticals International, plc | $6.05B | Mid cap | +133.47% |
| RDNT | RadNet, Inc. | $6.05B | Mid cap | +7.27% |
| MIRM | Mirum Pharmaceuticals, Inc. | $5.98B | Mid cap | +31.96% |
| DFTX | Definium Therapeutics, Inc. | $5.88B | Mid cap | +344.37% |
| TFX | Teleflex Incorporated | $5.88B | Mid cap | +8.06% |
| LGND | Ligand Pharmaceuticals Incorporated | $5.74B | Mid cap | +80.92% |
| CRSP | CRISPR Therapeutics AG | $5.73B | Mid cap | +10.65% |
| SHC | Sotera Health Company | $5.58B | Mid cap | +18.42% |
| MMSI | Merit Medical Systems, Inc. | $5.44B | Mid cap | −0.28% |
| ACAD | ACADIA Pharmaceuticals Inc. | $5.07B | Mid cap | +11.33% |
| DYN | Dyne Therapeutics, Inc. | $4.92B | Mid cap | +93.26% |
| HAE | Haemonetics Corporation | $4.85B | Mid cap | +93.71% |
| EWTX | Edgewise Therapeutics, Inc. | $4.80B | Mid cap | +207.13% |
| LFST | LifeStance Health Group, Inc. | $4.69B | Mid cap | +121.31% |
| BLLN | BillionToOne, Inc. | $4.54B | Mid cap | −11.68% |
| ICUI | ICU Medical, Inc. | $4.49B | Mid cap | +41.83% |
| NVST | Envista Holdings Corporation | $4.47B | Mid cap | +30.89% |
| ELVN | Enliven Therapeutics, Inc. | $4.46B | Mid cap | +194.32% |
| CON | Concentra Group Holdings Parent, Inc. | $4.44B | Mid cap | +50.93% |
| LIVN | LivaNova PLC | $4.41B | Mid cap | +41.56% |
| TNGX | Tango Therapeutics, Inc. | $4.29B | Mid cap | +269.13% |
| RLAY | Relay Therapeutics, Inc. | $4.26B | Mid cap | +445.10% |
| HTFL | Heartflow, Inc. | $4.26B | Mid cap | +40.79% |
| ITGR | Integer Holdings Corporation | $4.25B | Mid cap | +15.84% |
| INDV | Indivior Pharmaceuticals, Inc. | $4.23B | Mid cap | +47.06% |
| ADPT | Adaptive Biotechnologies Corporation | $4.18B | Mid cap | +101.70% |
| AMLX | Amylyx Pharmaceuticals, Inc. | $4.13B | Mid cap | +292.38% |
| IDYA | IDEAYA Biosciences, Inc. | $4.01B | Mid cap | +66.32% |
| VKTX | Viking Therapeutics, Inc. | $4.01B | Mid cap | +29.15% |
| DNLI | Denali Therapeutics Inc. | $3.98B | Mid cap | +57.50% |
| ABCL | AbCellera Biologics Inc. | $3.97B | Mid cap | +181.38% |
| RCUS | Arcus Biosciences, Inc. | $3.92B | Mid cap | +191.29% |
| CPRX | Catalyst Pharmaceuticals Inc | $3.85B | Mid cap | +55.97% |
| TLX | Telix Pharmaceuticals Limited | $3.77B | Mid cap | −8.02% |
| IOVA | Iovance Biotherapeutics, Inc. | $3.66B | Mid cap | +233.88% |
| OGN | Organon & Co. | $3.62B | Mid cap | +50.67% |
| VCYT | Veracyte, Inc. Common Stock | $3.56B | Mid cap | +54.81% |
| GRAL | GRAIL, Inc. | $3.55B | Mid cap | +136.66% |
| QURE | uniQure N.V. | $3.53B | Mid cap | +223.49% |
| NHC | National HealthCare Corporation | $3.53B | Mid cap | +103.83% |
| PLSE | Pulse Biosciences, Inc. | $3.43B | Mid cap | +203.47% |
| IMNM | Immunome, Inc. | $3.34B | Mid cap | +188.94% |
| MRVI | Maravai LifeSciences Holdings, Inc. | $3.30B | Mid cap | +281.97% |
| MBX | MBX Biosciences, Inc. | $3.22B | Mid cap | +366.53% |
| BEAM | Beam Therapeutics Inc. | $3.21B | Mid cap | +79.06% |
| CLDX | Celldex Therapeutics, Inc. | $3.19B | Mid cap | +79.51% |
| IRON | Disc Medicine, Inc. | $3.17B | Mid cap | +37.90% |
| WRBY | Warby Parker Inc. | $3.15B | Mid cap | −3.96% |
| TARS | Tarsus Pharmaceuticals, Inc. | $3.10B | Mid cap | +22.19% |
| ALMS | Alumis Inc. | $3.06B | Mid cap | +380.08% |
| AVAH | Aveanna Healthcare Holdings Inc. | $2.97B | Mid cap | +73.50% |
| ZLAB | Zai Lab Limited | $2.92B | Mid cap | −20.06% |
| ACHC | Acadia Healthcare Company, Inc. | $2.85B | Mid cap | +37.81% |
| SLS | SELLAS Life Sciences Group, Inc. | $2.77B | Mid cap | +615.10% |
| NRIX | Nurix Therapeutics, Inc. | $2.77B | Mid cap | +179.69% |
| VRDN | Viridian Therapeutics, Inc. | $2.75B | Mid cap | +30.71% |
| ATAI | AtaiBeckley Inc. | $2.74B | Mid cap | +61.71% |
| WGS | GeneDx Holdings Corp. | $2.69B | Mid cap | −30.11% |
| AXGN | AxoGen, Inc. Common Stock | $2.68B | Mid cap | +219.58% |
| PGEN | Precigen, Inc. | $2.65B | Mid cap | +61.66% |
| CDNA | CareDx, Inc. | $2.64B | Mid cap | +283.45% |
| RARE | Ultragenyx Pharmaceutical Inc. | $2.61B | Mid cap | −12.10% |
| PHVS | Pharvaris N.V. | $2.60B | Mid cap | +55.59% |
| BHVN | Biohaven Ltd. | $2.56B | Mid cap | +8.65% |
| TRVI | Trevi Therapeutics, Inc. | $2.55B | Mid cap | +124.00% |
| NEOG | Neogen Corporation | $2.54B | Mid cap | +103.83% |
| RAPP | Rapport Therapeutics, Inc. | $2.52B | Mid cap | +250.70% |
| NKTR | Nektar Therapeutics | $2.52B | Mid cap | +151.95% |
| BCRX | BioCryst Pharmaceuticals, Inc. | $2.51B | Mid cap | +15.38% |
| KOD | Kodiak Sciences Inc. | $2.48B | Mid cap | +321.09% |
| ATRC | AtriCure, Inc. | $2.45B | Mid cap | +29.14% |
| NUVB | Nuvation Bio Inc. | $2.44B | Mid cap | +135.93% |
| BHC | Bausch Health Companies Inc. | $2.43B | Mid cap | −10.45% |
| OCUL | Ocular Therapeutix, Inc. | $2.37B | Mid cap | −12.58% |
| GRDN | Guardian Pharmacy Services, Inc. | $2.36B | Mid cap | +45.50% |
| UFPT | UFP Technologies, Inc. | $2.36B | Mid cap | +41.94% |
| HRMY | Harmony Biosciences Holdings, Inc. | $2.31B | Mid cap | +4.23% |
| BFLY | Butterfly Network, Inc. | $2.30B | Mid cap | +450.32% |
| NEO | NeoGenomics, Inc. | $2.26B | Mid cap | +145.34% |
| NBTX | Nanobiotix S.A. | $2.26B | Mid cap | +394.99% |
| CLOV | Clover Health Investments, Corp. | $2.26B | Mid cap | +57.99% |
| ADUS | Addus HomeCare Corporation | $2.25B | Mid cap | +4.50% |
| URGN | UroGen Pharma Ltd. | $2.25B | Mid cap | +135.11% |
| MESO | Mesoblast Limited | $2.23B | Mid cap | +4.47% |
| PVLA | Palvella Therapeutics, Inc. | $2.22B | Mid cap | +173.39% |
| AUPH | Aurinia Pharmaceuticals Inc. | $2.20B | Mid cap | +36.58% |
| MD | Pediatrix Medical Group, Inc. | $2.19B | Mid cap | +56.87% |
| VCEL | Vericel Corporation | $2.17B | Mid cap | +18.25% |
| ZBIO | Zenas BioPharma, Inc. | $2.15B | Mid cap | +97.73% |
| STOK | Stoke Therapeutics, Inc. | $2.14B | Mid cap | +71.45% |
| XNCR | Xencor, Inc. Common Stock | $2.11B | Mid cap | +254.61% |
| ZYME | Zymeworks Inc. | $2.10B | Mid cap | +96.28% |
| NVCR | NovoCure Limited | $2.08B | Mid cap | +50.21% |
| SRPT | Sarepta Therapeutics, Inc. | $2.06B | Mid cap | +7.69% |
| PRGO | Perrigo Company plc | $2.05B | Mid cap | −36.05% |
| SEM | Select Medical Holdings Corp | $2.05B | Mid cap | +28.14% |
| AGIO | Agios Pharmaceuticals, Inc. Common Stock | $2.03B | Mid cap | −13.45% |
| CMPS | COMPASS Pathways plc | $2.02B | Mid cap | +209.53% |
| ATRA | Atara Biotherapeutics, Inc. | $94.15M | Micro cap | −24.05% |
| ACRV | Acrivon Therapeutics, Inc. | $93.42M | Micro cap | +52.94% |
| ECOR | electroCore, Inc. | $93.31M | Micro cap | +86.49% |
| ICCC | ImmuCell Corporation | $91.00M | Micro cap | +64.26% |
| RLYB | Rallybio Corporation | $89.64M | Micro cap | +257.63% |
| ATHE | Alterity Therapeutics Limited | $86.64M | Micro cap | −4.40% |
| CING | Cingulate Inc. | $85.36M | Micro cap | +29.19% |
| ACET | Adicet Bio, Inc. | $83.79M | Micro cap | −26.01% |
| APLM | Apollomics, Inc. | $76.75M | Micro cap | +320.55% |
| OSTX | OS Therapies Incorporated | $76.68M | Micro cap | −34.00% |
| LONA | LeonaBio, Inc. | $75.47M | Micro cap | +95.25% |
| NRXS | NeurAxis, Inc. | $74.84M | Micro cap | +146.28% |
| MNOV | MediciNova, Inc. | $72.85M | Micro cap | +10.45% |
| FBIOP | Fortress Biotech, Inc. | $71.45M | Micro cap | +131.74% |
| PMVP | PMV Pharmaceuticals, Inc. | $70.03M | Micro cap | −7.75% |
| INCR | InterCure Ltd. | $69.65M | Micro cap | +265.03% |
| INMB | INmune Bio Inc. | $67.86M | Micro cap | +19.56% |
| RNXT | RenovoRx, Inc. | $67.24M | Micro cap | +61.08% |
| SER | Serina Therapeutics, Inc. | $66.80M | Micro cap | −47.29% |
| BOLD | Boundless Bio, Inc. | $66.31M | Micro cap | +155.70% |
| TLPH | Talphera, Inc. | $65.40M | Micro cap | +133.33% |
| MYO | Myomo, Inc. | $60.60M | Micro cap | +36.61% |
| INKT | MiNK Therapeutics, Inc. | $60.16M | Micro cap | −26.22% |
| XLO | Xilio Therapeutics, Inc. | $59.55M | Micro cap | −5.63% |
| COCH | Envoy Medical, Inc. | $56.82M | Micro cap | −37.09% |
| SCYX | SCYNEXIS, Inc. | $56.41M | Micro cap | +579.04% |
| NTRB | Nutriband Inc. | $54.70M | Micro cap | −29.80% |
| PRPO | Precipio, Inc. | $54.43M | Micro cap | +99.25% |
| HOWL | Werewolf Therapeutics, Inc. | $48.05M | Micro cap | −25.65% |
| MLSS | Milestone Scientific Inc. | $47.87M | Micro cap | −10.10% |
| ALGS | Aligos Therapeutics, Inc. | $46.65M | Micro cap | −33.72% |
| ELUT | Elutia Inc. | $44.29M | Micro cap | −54.75% |
| NEPH | Nephros, Inc. | $43.98M | Micro cap | 0.00% |
| HBIO | Harvard Bioscience, Inc. | $34.83M | Micro cap | +44.34% |
| CCEL | Cryo-Cell International, Inc. | $34.67M | Micro cap | −3.19% |
| NSYS | Nortech Systems Incorporated | $33.62M | Micro cap | +30.74% |
| KYNB | Kyntra Bio, Inc. | $32.82M | Micro cap | −22.66% |
| RMTI | Rockwell Medical, Inc. | $31.90M | Micro cap | +438.44% |
| QNCX | Quince Therapeutics, Inc. | $31.84M | Micro cap | +100.71% |
| IGC | IGC Pharma, Inc. | $31.49M | Micro cap | −31.62% |
| BRNS | Barinthus Biotherapeutics plc | $28.86M | Micro cap | −38.04% |
| GRDX | GridAI Technologies Corp. | $28.75M | Micro cap | +111.52% |
| TXMD | TherapeuticsMD, Inc. | $26.39M | Micro cap | +103.57% |
| MRKR | Marker Therapeutics, Inc. | $24.18M | Micro cap | +54.26% |
| FEMY | Femasys Inc. | $23.87M | Micro cap | +711.11% |
| BFRI | Biofrontera Inc. | $22.72M | Micro cap | +77.91% |
| RVP | Retractable Technologies, Inc. | $21.85M | Micro cap | −12.05% |
| COCP | Cocrystal Pharma, Inc. | $21.57M | Micro cap | −27.74% |
| CCM | Concord Medical Services Holdings Limited | $21.49M | Micro cap | −10.47% |
| ALLR | Allarity Therapeutics, Inc. | $21.32M | Micro cap | −15.72% |
| LFWD | Lifeward Ltd. | $20.93M | Micro cap | +0.03% |
| PMI | Picard Medical, Inc. | $20.13M | Micro cap | +113.51% |
| NCEL | NewcelX Ltd. | $19.52M | Micro cap | −84.77% |
| VYNE | VYNE Therapeutics Inc | $19.07M | Micro cap | +8660.74% |
| LEXX | Lexaria Bioscience Corp. | $18.24M | Micro cap | +1146.05% |
| BCDA | BioCardia, Inc. | $18.02M | Micro cap | −38.66% |
| CYCN | Cyclerion Therapeutics, Inc. | $17.97M | Micro cap | +61.48% |
| BIVI | BioVie Inc. | $17.83M | Micro cap | +30.25% |
| ADIL | Adial Pharmaceuticals, Inc. | $17.43M | Micro cap | −37.47% |
| CMMB | Chemomab Therapeutics Ltd. | $16.85M | Micro cap | −25.57% |
| ADVB | Advanced Biomed Inc. | $15.27M | Micro cap | +13.24% |
| PHIO | Phio Pharmaceuticals Corp. | $13.94M | Micro cap | −40.89% |
| HSCS | HeartSciences Inc. | $13.47M | Micro cap | −11.54% |
| APRE | Aprea Therapeutics, Inc. | $12.34M | Micro cap | −38.75% |
| ASBP | Aspire Biopharma Holdings, Inc. | $11.68M | Micro cap | −60.93% |
| KPRX | Kiora Pharmaceuticals, Inc. | $11.46M | Micro cap | −9.44% |
| TOVX | Theriva Biologics, Inc. | $11.16M | Micro cap | −42.10% |
| LUCY | Lucyd, Inc | $9.73M | Micro cap | −42.05% |
| MBAI | Check-Cap Ltd. | $9.33M | Micro cap | +943.08% |
| BMGL | Basel Medical Group Ltd | $9.29M | Micro cap | +202.81% |
| IMRN | Immuron Limited | $9.20M | Micro cap | −35.77% |
| XBIO | Xenetic Biosciences, Inc. | $9.04M | Micro cap | +35.92% |
| SKYE | Skye Bioscience, Inc. | $8.92M | Micro cap | −41.62% |
| XWEL | XWELL, Inc. | $8.55M | Micro cap | −6.93% |
| CNSP | CNS Pharmaceuticals, Inc. | $8.48M | Micro cap | −13.51% |
| NDRA | ENDRA Life Sciences Inc. | $8.16M | Micro cap | +32.36% |
| ALZN | Alzamend Neuro, Inc. | $8.06M | Micro cap | −32.11% |
| NVNO | enVVeno Medical Corporation | $7.97M | Micro cap | −63.76% |
| ICCM | IceCure Medical Ltd | $7.85M | Micro cap | +132.49% |
| TRIB | Trinity Biotech plc | $7.80M | Micro cap | +547.97% |
| INM | InMed Pharmaceuticals Inc. | $7.64M | Micro cap | −36.44% |
| CURX | Curanex Pharmaceuticals Inc | $7.21M | Micro cap | −1.29% |
| JUNS | Jupiter Neurosciences, Inc. | $6.66M | Micro cap | +236.24% |
| AMIX | Autonomix Medical, Inc. | $6.20M | Micro cap | +440.68% |
| LIMN | Liminatus Pharma, Inc. | $6.19M | Micro cap | +46.03% |
| HCWB | HCW Biologics Inc. | $4.96M | Micro cap | −55.15% |
| XAIR | Beyond Air, Inc. | $4.89M | Micro cap | +117.98% |
| GLMD | Galmed Pharmaceuticals Ltd. | $4.48M | Micro cap | +211.51% |
| SILO | Silo Pharma, Inc. | $4.38M | Micro cap | +290.62% |
| UPC | Universe Pharmaceuticals INC | $3.53M | Micro cap | +44.57% |
| CLDI | Calidi Biotherapeutics, Inc. | $3.49M | Micro cap | −19.16% |
| TNON | Tenon Medical, Inc. | $3.48M | Micro cap | +297.71% |
| GNPX | Genprex, Inc. | $3.25M | Micro cap | −54.10% |
| BIAF | bioAffinity Technologies, Inc. | $3.02M | Micro cap | −31.59% |
| PFSA | Profusa, Inc. | $2.58M | Micro cap | −86.13% |
| VRAX | Virax Biolabs Group Limited | $2.21M | Micro cap | +365.55% |
| SHPH | Shuttle Pharmaceuticals Holdings, Inc. | $2.10M | Micro cap | +7.65% |
| MNDR | Mobile-health Network Solutions | $1.92M | Micro cap | −69.91% |
| SCNI | Scinai Immunotherapeutics Ltd. | $1.48M | Micro cap | +93.92% |
| APM | Aptorum Group Ltd | $570.06K | Micro cap | +273.78% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.